Current Therapy in CKD Patients Can Affect Vitamin K Status
نویسندگان
چکیده
منابع مشابه
Current status of bicarbonate in CKD.
Metabolic acidosis was one of the earliest complications to be recognized and explained pathologically in patients with CKD. Despite the accumulated evidence of deleterious effects of acidosis, treatment of acidosis has been tested very little, especially with respect to standard clinical outcomes. On the basis of fundamental research and small alkali supplementation trials, correcting metaboli...
متن کاملStatus of Vitamin-D in diabetic patients
Abstract Background: Vitamin D (vit D) deficiency has been found to have an inverse relationship with the occurrence of type-2 diabetes mellitus (DM). The aim of this study was to assess the vit D level in type-2 diabetic patients. Methods: One hundred-twenty DM patients selected as case group and 120 healthy individuals as control group were investigated in this study from October 2011 to S...
متن کاملCan Raising Vitamin D Status Slow Down Covid-19 Waves?
Several mitigation and suppression policies, such as social distancing, city lockdowns, remote working, testing, providing personal protective equipment and health care resource availability have been implemented by the governments in response to Covid-19 pandemic. Until now (October 23, 2020), over 1.14 million deaths in the world including 31,650 just in Iran have been officially attributed t...
متن کاملKeto Acid Therapy in CKD Patients Epidemiology of CKD Worldwide
s Am J Nephrol 2005;25(suppl 1):1–28 7 surveys and continuous patient data recording since 1996. On 31 December 2001, 1,164 facilities for dialysis and renal transplantation treatment were reported to the QuaSi-Niere-GmbH. The longitudinal data of more than 85,000 patients are available (diagnosis, modality, morbidity, follow-up). Concerning the worldwide end-stage renal disease (ESRD) populati...
متن کاملBleeding in very old patients on vitamin K antagonist therapy.
A common topic in clinical anticoagulation research used to be bleeding risk in old age. Times have changed, as well as the population of patients on anticoagulants, and the topic now is bleeding risk in very old patients. What is it about age that stimulates clinical investigators to launch studies of age and bleeding risk with vitamin K antagonist (VKA) therapy? First, the decision to initiat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nutrients
سال: 2020
ISSN: 2072-6643
DOI: 10.3390/nu12061609